ARX vs MVP

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

57MEDIUM

MVP

MEDICALDEV FPO [MVP]

57MEDIUM

Score Breakdown

ARX MVP
Technical
38
37
Catalyst
50
54
Sentiment
50
50
Fundamental
95
95
Momentum
55
49
Risk Gate
50
50

Key Metrics

ARX Metric MVP
$202.9MMarket Cap$45.6M
314KAvg Volume (20d)136K
N/AShort InterestN/A
$0.80052-Week High$0.765
$0.49552-Week Low$0.365
-0.8%Daily Change+0.0%
$0.580Reference Price$0.405
+4.9%ROE-0.8%
+4.5%Profit Margin-1.1%

Active Signals

ARX Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Above-average volume (1.6x) on a red day — sellers in control
●Sitting near support — this level has held before and could attract buyers again
●Drifting lower — down 3.3% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (2.0x)

MVP Signals

●MACD crossed bearish — momentum is fading
●Drifting lower — down 6.9% over the last 5 days
●Beating the Small Ords index — relative strength of 1.15, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●4C filed 2026-04-23
●Low P/S ratio (1.1x)
●Moderate revenue growth (+8%)

Ask Scout AI to compare ARX and MVP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ARX vs CGS →EYE vs MVP →CGS vs EYE →CGS vs MVP →AHC vs CMP →
ARX Full Analysis → MVP Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).